![Michael Pehl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Pehl
Verkställande Direktör på
ADCendo ApS
Profil
Michael Pehl is Chief Executive Officer & Director at ADCendo ApS since 2021.
Formerly, Mr. Pehl was President, Chief Executive Officer & Director at Immunomedics, Inc. from 2017 to 2019, Chief Executive Officer at AvenCell Europe GmbH, and President-Global Hematology/Oncology at Celgene Corp.
from 2006 to 2017.
Mr. Pehl completed undergraduate education at Ludwig-Maximilians-Universität München.
Aktiva positioner av Michael Pehl
| Företag | Position | Start |
|---|---|---|
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology Operates as a clinical-stage biotech company that dedicated to developing transformative first and best-in-class antibody-drug conjugate therapies for cancers | Verkställande Direktör | 2021-07-07 |
Tidigare kända positioner av Michael Pehl
| Företag | Position | Slut |
|---|---|---|
| IMMUNOMEDICS, INC. | Verkställande Direktör | 2019-02-23 |
| CELGENE | Företagsledare/Principal | 2017-08-21 |
GEMoaB Monoclonals GmbH
 GEMoaB Monoclonals GmbH Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Verkställande Direktör | - |
Michael Pehls utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADCendo ApS
ADCendo ApS BiotechnologyHealth Technology Operates as a clinical-stage biotech company that dedicated to developing transformative first and best-in-class antibody-drug conjugate therapies for cancers | Health Technology |
GEMoaB Monoclonals GmbH
GEMoaB Monoclonals GmbH Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
